Drugs Affecting Calcium

These drugs aim to mimic/antagonize the endogenous hormone PTH to maintain calcium homeostasis.

– The regulation of calcium is especially important as calcium phosphate is a large component of bones:

– In osteoporosis, bone turnover increases so that bone resorption is greater than bone formation, due to increased activity of osteoclasts.


Drugs which increase plasma calcium


This is a recombinant version of parathyroid hormone which is a full PTH agonist

– Intermittent exposure results in net bone formation –> used to treat osteoporosis

Side effects

• Hypercalcemia

• Osteosarcoma


This is a synthetic form of active vitamin D made by the kidney (1,25-DHCC).

– Vitamin D usually acts to increase calcium reabsorption from the kidney and small intestine.

– In reality, this drug actually has few effects on Calcium homeostasis

– Instead it is used as a topical cream to treat skin disorders like psoriasis.


This is a combination of calcium salt and vitamin D3.

– Used to increase serum Ca2+ in hypocalcaemia and Vitamin D deficiency

– Used to treat calcium deficiencies in the elderly and osteoporosis.

Drugs which increase plasma calcium


e.g. Alendronate + Etidronate (- dronate)

These are analogues of pyrophosphate (P-O-P) that bind directly to hydroxyapatite (inorganic salts) and stop the resorption of bone by osteoclasts.

– They are first line drugs both in the prevention and treatment of osteoporosis and hypercalcemia

Side effects

• Corrosive oesophagitis if patients do not take the drug with water and remain upright for 30 minutes

• Atypical stress fractures (especially of the proximal femoral shaft)


This is released by the parafollicular C-cells of the thyroid gland

– Interacts with osteoclasts to stop reabsorption of calcium from bone

– It reduces hypercalcemia due to Paget disease and hyperparathyroidism

– It is used as a marker of Medullary Carcinoma: a thyroid cancer that presents with localized amyloidosis due to polymerization of pro-calcitonin into b-sheets.


This is a monoclonal antibody which blocks the action of RANK ligand

– RANK ligand usually ligand binds to RANK receptor and promotes osteoclast activity

– This therefore reduces osteoclast activity –> treats osteoporosis

– Used in post-menopausal women who are intolerant to other drugs or have renal failure.


The parathyroid gland senses calcium via protein CaSR

– This drug activates CaSR which reduces the serum PTH

– Acts to decreased plasma Ca2+ to treat hyperparathyroidism.

N.B. It is important to remember that several drugs indirectly affect Calcium homeostasis too:

– Thiazide diuretics –> reduce renal calcium excretion

– Loop diuretics –> increase renal calcium excretion

– Glucocorticoids increase bone resorption and stop absorption in intestine –> net decrease in calcium

– Oestrogens impair action of PTH –> used in the treatment of osteoporosis


The intended purpose of this website is to be used as a resource for revision for exams. It should not be used as a guideline or reference for clinical practice/decision making or by patients looking for medical information or advice. In2Med takes no responsibility for any loss or damaged resulting from the use of information from this website.

Applying for the SFP?


Check out our SFP crash course!